Kepos Capital LP Transcode Therapeutics, Inc. Call Options Transaction History
Kepos Capital LP
- $258 Million
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding RNAZ
# of Institutions
1Shares Held
6.5KCall Options Held
0Put Options Held
0About Transcode Therapeutics, Inc.
- Ticker RNAZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,977,200
- Market Cap $5.84M
- Description
- TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs incl...